CORREVIO PHARMA CORP's ticker is CORV and the CUSIP is 22026V105. A total of 23 filers reported holding CORREVIO PHARMA CORP in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $108,000 | +9.1% | 278,400 | +15.7% | 0.00% | – |
| Q4 2019 | $99,000 | -90.6% | 240,714 | -54.5% | 0.00% | -100.0% |
| Q3 2019 | $1,058,000 | -13.7% | 528,975 | -6.8% | 0.00% | 0.0% |
| Q2 2019 | $1,226,000 | -37.5% | 567,648 | -8.6% | 0.00% | -50.0% |
| Q1 2019 | $1,962,000 | +9.7% | 620,948 | -13.5% | 0.00% | 0.0% |
| Q4 2018 | $1,788,000 | -39.8% | 718,048 | -2.9% | 0.00% | -33.3% |
| Q3 2018 | $2,972,000 | +29.9% | 739,248 | +22.1% | 0.00% | +200.0% |
| Q2 2018 | $2,288,000 | – | 605,423 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 3,475,000 | $10,981,000 | 31.51% |
| Tamarack Advisers, LP | 2,400,000 | $7,584,000 | 3.01% |
| Columbia Pacific Advisors, LLC | 130,709 | $413,000 | 0.96% |
| CLOUGH CAPITAL PARTNERS L P | 2,111,224 | $6,671,000 | 0.58% |
| Worth Venture Partners, LLC | 172,066 | $544,000 | 0.30% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 577,133 | $1,824,000 | 0.27% |
| ARS Investment Partners, LLC | 337,868 | $1,068,000 | 0.19% |
| Rock Springs Capital Management LP | 1,200,000 | $3,792,000 | 0.15% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 4,788,032 | $15,130,000 | 0.12% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 122,817 | $388,000 | 0.02% |